Showing results (1171-1180 of 1,922) with videos related to

Sort By:
Pageof 193
Lancet (London, England)|August 21, 2012
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trialIan D Pavord, Stephanie Korn, Peter Howarth, et al.
Journal of the American Society of Nephrology : JASN|November 9, 2022
The Role of Platelet-Derived Growth Factor in Focal Segmental GlomerulosclerosisTing Jia, Tong Xu, Bart Smeets, et al.
Journal of Applied Crystallography|June 7, 2024
Phase-contrast neutron imaging compared with wave propagation and McStas simulationsEstrid Buhl Naver, Mads Bertelsen, Maja Østergaard, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|May 18, 2026
Age-related dermatoscopic features of excised melanomas versus nevi in 832 high risk patientsJana Burghaus-Zhang, Julia Katharina Winkler, Katharina Susanne Kommoss, et al.
Clinical Nutrition ESPEN|May 27, 2022
Relationship between physical frailty, nutritional risk factors and protein intake in community-dwelling older adultsSussi Friis Buhl, Anne Marie Beck, Pia Øllgaard Olsen, et al.
American Journal of Physiology. Renal Physiology|May 15, 2015
Aberrant glomerular filtration of urokinase-type plasminogen activator in nephrotic syndrome leads to amiloride-sensitive plasminogen activation in urineMette Stæhr, Kristian B Buhl, René F Andersen, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|August 27, 2025
Optimized Autologous Serum and Activated Leukocyte-Poor Platelet-Rich Plasma Eye Drops Production Protocol: Effect of Fasting, Filtering, and Complement Inactivation on the Concentration of Growth Factors and LipidsFrantisek Sanak, Katja Iselin, Claude Kaufmann, et al.
Scandinavian Journal of Immunology|March 17, 2001
Effects of subcutaneous IL-2 therapy on telomere lengths in PBMC in HIV-infected patientsH Aladdin, C S Larsen, P Schjerling, et al.
Pageof 193